Infant formula recall
This article was originally published in The Tan Sheet
Mead Johnson is issuing a recall of 41,464 GENTLEASE powdered infant formula cans due to contamination with metal particles up to 2.7 mm in size, FDA announces Feb. 22. Though no injuries have been reported to date, the particles could damage an infant's respiratory system and throat if inhaled into the lungs. Damage to the throat may cause coughing, difficulty swallowing or difficulty breathing, according to FDA, while similar damage to the lungs could provoke coughing and difficulty breathing. The 24-ounce cans were distributed through major retail stores across the country beginning Dec. 16, 2005. The recalled lot is identified by number BMJ19 and an expiration/use-by date of 1 Jul 07 embossed on the bottom of the can...
You may also be interested in...
Legal experts tell the Pink Sheet why India’s plans to abolish the Intellectual Property Appellate Board and shift its powers to courts may be problematic for stakeholders, including those pursuing infringement charges. The transition could mean a significant burden on courts both in terms of capability and capacity, and IPR cases will now conflate into all other pending commercial matters, some experts said, though others cheered the proposed change.
Tyto Care’s remote monitoring and telehealth platform has seen rising demand since the start of the pandemic and the company continues to expand. This week, it announced it raised $50m in a series D financing round. See what Dedi Gilad, CEO of Tyto Care, said about it here.
Focusing on orphan-first drugs may be best route to address pricing concerns, Health Affairs study suggests after finding that just one-fifth of spending on 15 top-selling partial orphan drugs was for the drugs’ rare disease indications.